Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

SRPT | Sarepta Therapeutics Inc

Index- P/E- EPS (ttm)-10.31 Insider Own5.69% Shs Outstand93.28M Perf Week-2.80%
Market Cap10.70B Forward P/E44.79 EPS next Y2.56 Insider Trans1.02% Shs Float87.97M Perf Month-1.09%
Income-907.68M PEG- EPS next Q-1.26 Inst Own86.89% Short Float / Ratio5.24% / 4.51 Perf Quarter5.97%
Sales1.00B P/S10.67 EPS this Y-2.35% Inst Trans6.46% Short Interest4.61M Perf Half Y-10.62%
Book/sh7.95 P/B14.43 EPS next Y- ROA-29.65% Target Price117.11 Perf Year4.18%
Cash/sh19.95 P/C5.75 EPS next 5Y41.76% ROE-123.67% 52W Range100.15 - 159.89 Perf YTD-11.45%
Dividend- P/FCF- EPS past 5Y-56.35% ROI-43.10% 52W High-28.24% Beta0.93
Dividend %- Quick Ratio4.50 Sales past 5Y45.19% Gross Margin81.74% 52W Low14.57% ATR3.05
Employees1162 Current Ratio4.96 Sales Q/Q11.89% Oper. Margin-50.80% RSI (14)43.39 Volatility3.14% 2.32%
OptionableYes Debt/Eq1.84 EPS Q/Q89.80% Profit Margin-90.46% Rel Volume1.68 Prev Close119.93
ShortableYes LT Debt/Eq1.84 EarningsAug 02 AMC Payout- Avg Volume1.02M Price114.74
Recom1.50 SMA20-4.23% SMA501.73% SMA200-7.47% Volume1,712,902 Change-4.33%
Date Action Analyst Rating Change Price Target Change
Jun-23-23Downgrade Evercore ISI Outperform → In-line $139
Apr-26-23Initiated SMBC Nikko Outperform $185
Apr-04-23Initiated Citigroup Buy $179
Mar-01-23Upgrade Morgan Stanley Equal-Weight → Overweight $141 → $187
Dec-22-22Reiterated BTIG Research Buy $125 → $160
Dec-16-22Upgrade UBS Neutral → Buy $100 → $158
Apr-04-22Resumed Cantor Fitzgerald Overweight $140
Jan-05-22Reiterated Needham Buy $157 → $150
Dec-09-21Upgrade Oppenheimer Perform → Outperform $125
Nov-05-21Upgrade JP Morgan Neutral → Overweight $130
Sep-15-23 12:50PM
08:37AM
Sep-14-23 10:07AM
Sep-07-23 09:00AM
Sep-05-23 08:30AM
11:31AM Loading…
Sep-01-23 11:31AM
Aug-31-23 06:15PM
Aug-30-23 11:09AM
08:40AM
Aug-27-23 07:20PM
Aug-23-23 01:00PM
Aug-22-23 10:00AM
Aug-13-23 08:08AM
Aug-04-23 03:22PM
Aug-03-23 11:28AM
09:00PM Loading…
Aug-02-23 09:00PM
06:15PM
05:08PM
04:05PM
Jul-31-23 06:08PM
Jul-29-23 11:39AM
Jul-27-23 07:30AM
Jul-26-23 10:02AM
08:30AM
Jul-25-23 10:01AM
Jul-16-23 08:20AM
Jul-12-23 05:33PM
Jul-05-23 08:30AM
Jul-03-23 08:30AM
Jun-30-23 06:20PM
08:45AM Loading…
08:45AM
Jun-29-23 09:02AM
Jun-23-23 04:07PM
Jun-22-23 05:17PM
04:02PM
03:02PM
02:24PM
02:23PM
02:08PM
02:02PM
Jun-17-23 09:45AM
Jun-12-23 09:30AM
Jun-08-23 11:30AM
Jun-01-23 11:31AM
10:04AM
06:45AM
May-31-23 06:16PM
May-24-23 04:04PM
01:53PM
12:28PM
09:53AM
08:24AM
08:07AM
08:00AM
May-16-23 03:42PM
08:30AM
May-15-23 04:05PM
12:48PM
10:59AM
10:30AM
08:53AM
08:33AM
May-14-23 04:00PM
May-12-23 07:02PM
06:18PM
12:37PM
09:49AM
May-11-23 02:23PM
May-10-23 09:32AM
May-08-23 02:32AM
May-05-23 02:30PM
May-04-23 10:05AM
May-03-23 11:36AM
07:27AM
12:00AM
May-02-23 05:35PM
04:05PM
Apr-28-23 06:15PM
Apr-26-23 10:02AM
Apr-25-23 08:30AM
Apr-19-23 09:14AM
Apr-13-23 04:05PM
11:03AM
10:17AM
09:29AM
Apr-10-23 09:37AM
Apr-06-23 05:39AM
Mar-31-23 06:25PM
Mar-30-23 11:30AM
Mar-29-23 09:26AM
Mar-25-23 06:00AM
Mar-21-23 04:16PM
03:02AM
Mar-17-23 04:05PM
02:54PM
02:00PM
01:20PM
11:39AM
11:22AM
09:50AM
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chambers Michael AndrewDirectorAug 14Buy109.479,9791,092,429246,996Aug 15 08:00 AM
Chambers Michael AndrewDirectorAug 11Buy108.0523,6862,559,272237,017Aug 14 08:00 AM
Chambers Michael AndrewDirectorAug 10Buy106.1534,8673,701,067213,331Aug 11 07:40 AM
Wigzell Hans Lennart RudolfDirectorAug 04Option Exercise29.0315,000435,45035,994Aug 08 08:00 PM
Wigzell Hans Lennart RudolfDirectorAug 04Sale106.7215,0001,600,80020,994Aug 08 08:00 PM
BEHRENS M KATHLEENDirectorDec 19Option Exercise34.9220,000698,400158,470Dec 21 09:05 AM
Mayo StephenDirectorNov 17Sale109.9285894,3116,387Nov 21 08:00 PM